CD36 and metastatic malignant neoplasm in the lymph nodes: Considering the important data of Pascual et al., who see CD36 as the key player in the development of lymph node metastasis in OSCC, it remains to be discussed why patients with lymph node metastasis have low CD36 expression [18].